Axim Biotechnologies Inc

AXIM Biotechnologies, Inc. operates as a biopharmaceutical and diagnostic company. The Company focuses on discovery and development of small molecule and monoclonal antibody therapies that disrupt extracellular matrix formation to block tumor cell growth and metastasis. AXIM Biotechnologies serves clients in the United States.